Literature DB >> 16649987

The mitochondrial permeability transition from in vitro artifact to disease target.

Paolo Bernardi1, Alexandra Krauskopf, Emy Basso, Valeria Petronilli, Elizabeth Blachly-Dyson, Elizabeth Blalchy-Dyson, Fabio Di Lisa, Michael A Forte.   

Abstract

The mitochondrial permeability transition pore is a high conductance channel whose opening leads to an increase of mitochondrial inner membrane permeability to solutes with molecular masses up to approximately 1500 Da. In this review we trace the rise of the permeability transition pore from the status of in vitro artifact to that of effector mechanism of cell death. We then cover recent results based on genetic inactivation of putative permeability transition pore components, and discuss their meaning for our understanding of pore structure. Finally, we discuss evidence indicating that the permeability transition pore plays a role in pathophysiology, with specific emphasis on in vivo models of disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16649987     DOI: 10.1111/j.1742-4658.2006.05213.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  230 in total

Review 1.  Mechanisms of ethanol-induced death of cerebellar granule cells.

Authors:  Jia Luo
Journal:  Cerebellum       Date:  2012-03       Impact factor: 3.847

2.  Mitochondria from Dipodascus (Endomyces) magnusii and Yarrowia lipolytica yeasts did not undergo a Ca²⁺-dependent permeability transition even under anaerobic conditions.

Authors:  Tat'yana Trendeleva; Evgeniya Sukhanova; Ludmila Ural'skaya; Nils-Erik Saris; Renata Zvyagilskaya
Journal:  J Bioenerg Biomembr       Date:  2011-12       Impact factor: 2.945

3.  Protective function of nicotinamide against ketamine-induced apoptotic neurodegeneration in the infant rat brain.

Authors:  Najeeb Ullah; Ikram Ullah; Hae Young Lee; Muhammad Imran Naseer; Park Moon Seok; Jawad Ahmed; Myeong Ok Kim
Journal:  J Mol Neurosci       Date:  2011-12-08       Impact factor: 3.444

Review 4.  Measuring mitochondrial function in intact cardiac myocytes.

Authors:  Elena N Dedkova; Lothar A Blatter
Journal:  J Mol Cell Cardiol       Date:  2011-09-22       Impact factor: 5.000

Review 5.  Mitofusins and the mitochondrial permeability transition: the potential downside of mitochondrial fusion.

Authors:  Kyriakos N Papanicolaou; Matthew M Phillippo; Kenneth Walsh
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-05-25       Impact factor: 4.733

6.  Reduced capacity of Ca²+ retention in liver as compared to kidney mitochondria. ADP requirement.

Authors:  Cecilia Zazueta; Noemí García; Eduardo Martínez-Abundis; Natalia Pavón; Luz Hernández-Esquivel; Edmundo Chávez
Journal:  J Bioenerg Biomembr       Date:  2010-08-20       Impact factor: 2.945

7.  Quantitative proteomics discloses MET expression in mitochondria as a direct target of MET kinase inhibitor in cancer cells.

Authors:  Tiannan Guo; Yi Zhu; Chee Sian Gan; Sze Sing Lee; Jiang Zhu; Haixia Wang; Xin Li; James Christensen; Shiang Huang; Oi Lian Kon; Siu Kwan Sze
Journal:  Mol Cell Proteomics       Date:  2010-08-16       Impact factor: 5.911

8.  Mitochondrial permeability transition pore regulates Parkinson's disease development in mutant α-synuclein transgenic mice.

Authors:  Lee J Martin; Samantha Semenkow; Allison Hanaford; Margaret Wong
Journal:  Neurobiol Aging       Date:  2013-11-16       Impact factor: 4.673

9.  The protective effect of α-Lipoic acid on mitochondria in the kidney of diabetic rats.

Authors:  Li Wang; Chen-Guang Wu; Chun-Qian Fang; Jing Gao; Ying-Zhao Liu; Yan Chen; Yu-Ning Chen; Zhi-Gang Xu
Journal:  Int J Clin Exp Med       Date:  2013-01-26

Review 10.  Brain vulnerability and viability after ischaemia.

Authors:  Stefano G Daniele; Georg Trummer; Konstantin A Hossmann; Zvonimir Vrselja; Christoph Benk; Kevin T Gobeske; Domagoj Damjanovic; David Andrijevic; Jan-Steffen Pooth; David Dellal; Friedhelm Beyersdorf; Nenad Sestan
Journal:  Nat Rev Neurosci       Date:  2021-07-21       Impact factor: 34.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.